1. Home
  2. RCKT vs XNET Comparison

RCKT vs XNET Comparison

Compare RCKT & XNET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

HOLD

Current Price

$3.91

Market Cap

401.6M

Sector

Health Care

ML Signal

HOLD

Logo Xunlei Limited

XNET

Xunlei Limited

HOLD

Current Price

$5.73

Market Cap

358.4M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCKT
XNET
Founded
1999
2003
Country
United States
China
Employees
202
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
401.6M
358.4M
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
RCKT
XNET
Price
$3.91
$5.73
Analyst Decision
Buy
Analyst Count
14
0
Target Price
$29.73
N/A
AVG Volume (30 Days)
3.2M
513.8K
Earning Date
05-04-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$64.28
N/A
P/E Ratio
N/A
$0.29
Revenue Growth
N/A
N/A
52 Week Low
$2.53
$4.14
52 Week High
$5.45
$11.03

Technical Indicators

Market Signals
Indicator
RCKT
XNET
Relative Strength Index (RSI) 64.16 56.13
Support Level $3.01 $5.31
Resistance Level $4.04 $6.09
Average True Range (ATR) 0.26 0.34
MACD 0.09 0.08
Stochastic Oscillator 69.32 77.42

Price Performance

Historical Comparison
RCKT
XNET

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

About XNET Xunlei Limited

Xunlei Ltd is a cloud-based acceleration technology company in China. The company operates a powerful internet platform in China based on cloud computing to provide users with quick and easy access to digital media content through its products and services, Xunlei Accelerator, and cloud acceleration subscription services. It is increasingly extending into mobile devices in part through potentially pre-installed acceleration products in mobile phones Xunlei has developed various value-added services to meet a fuller spectrum of its users' digital media content access and consumption needs.

Share on Social Networks: